Virios Therapeutics Inc (NASDAQ: VIRI) is -18.30% lower on its value in year-to-date trading and has touched a low of $0.28 and a high of $2.42 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VIRI stock was last observed hovering at around $0.46 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $0.47, the stock is 33.23% and 9.95% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.27 million and changing 2.71% at the moment leaves the stock -48.77% off its SMA200. VIRI registered 51.55% gain for a year compared to 6-month loss of -50.02%. The firm has a 200-day simple moving average (SMA200) of -$1.05.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 42.49% gain in the last 1 month and extending the period to 3 months gives it a -18.86%, and is 46.81% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 34.17% over the week and 16.81% over the month.
Virios Therapeutics Inc (VIRI) has around 4 employees, a market worth around $9.05M and $0.00M in sales. Distance from 52-week low is 70.84% and -80.59% from its 52-week high. The company has generated returns on investments over the last 12 months (-139.12%).
Virios Therapeutics Inc quarterly earnings per share for the current quarter are estimated at -$0.04.The EPS is expected to grow by 39.29% this year.
Virios Therapeutics Inc (VIRI) Top Institutional Holders
23 institutions hold shares in Virios Therapeutics Inc (VIRI), with institutional investors hold 8.99% of the company’s shares. The shares outstanding are 18.33M, and float is at 14.86M with Short Float at 0.65%. Institutions hold 8.12% of the Float.
The top institutional shareholder in the company is Vanguard Group Inc with over 0.21 million shares valued at $98133.0. The investor’s holdings represent 1.08% of the VIRI Shares outstanding. As of Dec 30, 2023, the second largest holder is Renaissance Technologies, LLC with 0.21 million shares valued at $97106.0 to account for 1.07% of the shares outstanding. The other top investors are Geode Capital Management, LLC which holds 0.17 million shares representing 0.91% and valued at over $81965.0, while State Street Corporation holds 0.27% of the shares totaling 52828.0 with a market value of $24818.0.
Virios Therapeutics Inc (VIRI) Insider Activity
The most recent transaction is an insider purchase by Pridgen William,the company’sDirector. SEC filings show that Pridgen William bought 15,335 shares of the company’s common stock on Aug 21 ’23 at a price of $1.30 per share for a total of $19992.0. Following the purchase, the insider now owns 52045.0 shares.
Virios Therapeutics Inc disclosed in a document filed with the SEC on Aug 17 ’23 that Duncan Gregory Scott (CHIEF EXECUTIVE OFFICER) bought a total of 25,000 shares of the company’s common stock. The trade occurred on Aug 17 ’23 and was made at $1.25 per share for $31245.0. Following the transaction, the insider now directly holds 57461.0 shares of the VIRI stock.
